Welcome to Janssen Immunology Clinical Studies
We are committed to finding new treatment options for patients with immune-mediated inflammatory diseases (IMIDs).
Click on the “View Study” buttons below to view the Clinical Studies information
anti-tumor necrosis factor therapies compared with guselkumab monotherapy
long-term safety of ustekinumab in the treatment of pediatric participants aged 6 years and older with moderate to severe plaque psoriasis
JNJ-78934804 compared with guselkumab and golimumab in adult participants with moderately to severely active ulcerative colitis
Correct as of August 2023
For investigational agents or
investigational uses of products, the safety and efficacy have not been determined. There is no
guarantee that the investigational agents listed will be filed with and/or approved for marketing by
the FDA. For additional information you may visit www.clinicaltrials.gov.
© Janssen Biotech, Inc. 2023. All rights reserved.
cp-182260v8
This site is published by Janssen Biotech, Inc., which is solely responsible for its contents. This site is intended for use by healthcare professionals of the United States and Puerto Rico. Janssen Biotech, Inc., recognizes that the Internet is a global communications medium; however, laws, regulatory requirements, and medical practices for pharmaceutical products vary from country to country. The Prescribing Information that may be included here may not be appropriate for use outside the United States and Puerto Rico.
Third-party trademarks used herein are trademarks of their respective owners.
You are now entering the medical affairs booth (microsite). Travel between the promotional and medical affairs booth is prohibited.
Medical Inquiries
United States
Healthcare professionals, patients, or caregivers in the United States may contact the Medical Information Center by visiting www.askjanssenmedinfo.com or by calling 1‑800‑JANSSEN (1‑800‑526‑7736) to speak to a clinical expert regarding their question or to report a possible adverse event or product quality complaint.
Healthcare professionals in the United States may also contact their local Medical Science Liaison (MSL) by visiting www.JanssenMSL.com. MSLs are scientific and healthcare professionals that are available to respond via phone, email, or in person to clinical and scientific inquiries.
Outside of the United States
If you are seeking medical information or would like to report an Adverse Event (medication side effect) or Product Quality Complaint (problem with one of our products), please use the email address for the country where you are located. View this PDF for country‑specific information.
